Trautman, H., Clark, J., Huleatt, H., Oleen-Burkey, M., & Brewster, C. (2011). PND26 Estimated Costs of First-Year Monitoring and Administration of Multiple Sclerosis Therapies in the United States. Value in Health, A322. https://doi.org/10.1016/j.jval.2011.08.492
Chicago Style (17th ed.) CitationTrautman, H.C, J.A Clark, H. Huleatt, M. Oleen-Burkey, and C. Brewster. "PND26 Estimated Costs of First-Year Monitoring and Administration of Multiple Sclerosis Therapies in the United States." Value in Health 2011: A322. https://doi.org/10.1016/j.jval.2011.08.492.
MLA (9th ed.) CitationTrautman, H.C, et al. "PND26 Estimated Costs of First-Year Monitoring and Administration of Multiple Sclerosis Therapies in the United States." Value in Health, 2011, p. A322, https://doi.org/10.1016/j.jval.2011.08.492.